- the INK4a locus encodes for two proteins, p16 and p14ARF (alternative reading frame)
- mutations within the INK4a locus have been found in familial melanomas (20%)
- p16 is a protein that blocks the action of cyclin-dependent kinase D which
complexes with cyclin D to phosphorylate the retinoblastoma protein to allow
for the cell to cycle
- inactivation of p16 occurs through mutations and epigenetic changes
- mutations of the p16INK4a have been found in many tumors, including pancreatic tumors,
head and neck squamous cell carcinomas
- in cervical cancer, p16 is inactivated through CpG island hypermethylation
- p14ARF is a negative regulator of MDM2
- MDM2 negatively inhibits p53
- loss of p14ARF allows MDM2 to constantly target p53 for degradation, thereby
allowing the cell to cycle autonomously, without arrest and without repair
of DNA damage
- commonly mutated in colon cancers and gastric cancers
- SMAD4 gene codes for a protein that is involved within the TGF-beta pathway
- SMAD4 is mutated in most cancers of the pancreas
- von Hippel Lindau gene
- phosphatase and tensin homologue
Find links, information, methods, assays, kits, and articles on Tumor Suppressor Genes and Proteins. Please click on the left column categories.